Lipids and lipoproteins in diabetic adolescents and young adults with retinopathy

Eye
A VerrottiP E Gallenga

Abstract

To compare serum concentrations of lipoproteins and apolipoproteins in insulin-dependent diabetic patients with and without retinopathy. A cross-sectional study was performed on 42 diabetic adolescents and young adults with different degrees of retinopathy. The mean +/- SD age of the patient was 21.1 years (range 12.8-27.9 years); their mean duration of diabetes was 12.3 years (range 7.1-19.9 years). Their glycosylated haemoglobin (HbA1c) and fructosamine were respectively 10.2% (8.2-15.4%) and 280.8 mumol/l (202.1-458.5 mumol/l). Forty-two diabetics without retinopathy similar to the study population as regards age, sex, duration of disease, HbA1c and microalbuminuria values, and 42 healthy subjects, served as controls. Serum lipid and lipoprotein concentrations were not different from those of healthy controls in patients either with or without retinopathy. The diabetic patients were subdivided in two groups according to the degree of their retinopathy: background and preproliferative/proliferative retinopathy. Patients with preproliferative/proliferative retinopathy were found to have significantly higher lipoprotein (a) values than the other group (background, 73.3 IU/l; preproliferative/proliferative, 205.9 IU/l; p < 0.001...Continue Reading

References

Jul 1, 1992·Annals of Internal Medicine·L C RamirezP Raskin
Dec 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·P H WinocourP N Durrington
Jan 1, 1991·Acta diabetologica latina·A VerrottiG Morgese
May 24, 1986·Lancet·P H WinocourD C Anderson
Jan 1, 1988·Acta Medica Scandinavica·C D AgardhP Nilsson-Ehle
Feb 1, 1988·European Journal of Pediatrics·F ChiarelliG Morgese
Dec 5, 1985·The New England Journal of Medicine·L I RandT Maki
Dec 1, 1984·Ophthalmology·G C BrownL K Sarin
Jan 1, 1984·Ophthalmology·B E KleinS Syrjala
Jul 12, 1984·The New England Journal of Medicine·C E Mogensen, C K Christensen
Mar 20, 1980·The New England Journal of Medicine·J M SosenkoK H Gabbay
May 21, 1980·Clinica Chimica Acta; International Journal of Clinical Chemistry·P N Durrington
Mar 26, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·P N Durrington
Sep 1, 1994·Journal of the American Geriatrics Society·N MorisakiS Yoshida
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Jan 1, 1993·Diabetologia·M MaioliM Porta
Jan 31, 1993·Clinica Chimica Acta; International Journal of Clinical Chemistry·M M RitterP Schwandt
Sep 1, 1955·The Journal of Clinical Investigation·R J HAVELJ H BRAGDON

❮ Previous
Next ❯

Citations

Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Anoop MisraAtul Kumar
Mar 16, 2004·Pediatric Diabetes·C Giusti
Nov 30, 2011·Expert Opinion on Biological Therapy·Laurence S Lim, Tien Y Wong
Nov 13, 2001·American Journal of Ophthalmology·L P AielloJ S Wong
Feb 16, 2002·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·Tatsuya SuzukiHiroshi Nakano
Apr 9, 1999·Acta Paediatrica. Supplement·A VerrottiF Chiarelli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.